Baxter (Austria)

A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

Gabriela Stiegler, Renate Kunert, Martin Purtscher et al. · AIDS Research and Human Retroviruses · 2001 · 512 citations

Primary Immunodeficiency, Vitro Neutralizing Potency, Medicine +14

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 320 citations

Factor Viii Levels, Medicine, Hematology +7

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Michael Rieger · Blood · 2005 · 311 citations · Full text

The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy

Helen Chapel, G Spickett, Diddi Ericson et al. · Journal of Clinical Immunology · 2000 · 294 citations

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 292 citations · Full text